RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Oncogene

• Publication date

  2012-11-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2011.658PMID 22266866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

  2009cited by this paper
• Identification of a novel estrogen receptor beta1 binding partner, inhibitor of differentiation-1, and role of ERbeta1 in human breast cancer cells.

  2009cited by this paper
• RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt.

  2009cited by this paper
• Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response

  2008cited by this paper
• Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors

  2008cited by this paper
• Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.

  2007cited by this paper
• Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer.

  2007cited by this paper
• Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer

  2007cited by this paper
• Correlation between CpG methylation profiles and hormone receptor status in breast cancers

  2007cited by this paper
• Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

  2007cited by this paper
• STEROIDRECEPTORSANDPROLIFERATIONIN THE HUMANBREAST Results and Discussion Distribution of ER in Normal Human Breast Lobules

  2006cited by this paper
• International Union of Pharmacology. LXIV. Estrogen Receptors

  2006cited by this paper
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

  2006cited by this paper
• Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

  2006cited by this paper
• Altered Target Gene Regulation Controlled by Estrogen Receptor-α Concentration

  2006cited by this paper
• Altered target gene regulation controlled by estrogen receptor-alpha concentration.

  2006cited by this paper
• Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

  2006cited by this paper
• Integration of the extranuclear and nuclear actions of estrogen.

  2005cited by this paper
• Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis

  2005cited by this paper
• Chromatin Inactivation Precedes De Novo DNA Methylation during the Progressive Epigenetic Silencing of the RASSF1A Promoter

  2005cited by this paper
• The tumor suppressor RASSF1A in human carcinogenesis: an update.

  2005cited by this paper
• Transformation of Human and Murine Fibroblasts without Viral Oncoproteins

  2005cited by this paper
• Proximal Events in Signaling by Plasma Membrane Estrogen Receptors*

  2003cited by this paper
• Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo.

  2003cited by this paper
• Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase.

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Src Is an Initial Target of Sex Steroid Hormone Action

  2002cited by this paper
• Regulation of Raf-Akt Cross-talk

  2002cited by this paper
• ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions.

  2002cited by this paper
• Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta.

  2002cited by this paper
• Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.

  2002cited by this paper
• Mechanism of 17-β-Estradiol-induced Erk1/2 Activation in Breast Cancer Cells

  2002cited by this paper
• Mammary Gland Development in Adult Mice Requires Epithelial and Stromal Estrogen Receptor α.

  2002cited by this paper
• Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha.

  2002cited by this paper
• PI3‐kinase in concert with Src promotes the S‐phase entry of oestradiol‐stimulated MCF‐7 cells

  2001cited by this paper
• Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence

  2001cited by this paper
• BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

  2001cited by this paper
• Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3

  2001cited by this paper
• Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α

  2001cited by this paper
• Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.

  2001cited by this paper
• Abnormal regulation of the oestrogen receptor in benign breast lesions

  2000cited by this paper
• 17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.

  2000cited by this paper
• phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Expression of steroid hormone receptors, their regulated proteins, and bcl‐2 protein in myofibroblastoma of the breast

  2000cited by this paper
• A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.

  2000cited by this paper
• Oestrogen receptor expression in the normal and pre‐cancerous breast

  1999cited by this paper
• Expression of Bcl‐2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma

  1999cited by this paper
• Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.

  1999cited by this paper
• Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan.

  1999cited by this paper
• Estrogen receptor expression in benign breast epithelium and breast cancer risk.

  1998cited by this paper
• Coupling of Cell Growth Control and Apoptosis Functions of Id Proteins

  1998cited by this paper
• Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins

  1997cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• Regulation of G1 progression by E2A and Id helix‐loop‐helix proteins.

  1994cited by this paper
• Mechanism of estrogen activation of c-myc oncogene expression.

  1992cited by this paper
• Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts

  1990cited by this paper
• Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

  1990cited by this paper
• Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.

  1985cited by this paper

• Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women

  2025cites this paper
• Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring

  2025cites this paper
• Novel strategy for activating gene expression through triplex DNA formation targeting epigenetically suppressed genes

  2024cites this paper
• Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment

  2023cites this paper
• Expression of Extracellular Regulated Protein Kinase (ERK) & Promoter Methylation of RASSF1A In Endometrioid Endometrial Carcinoma and Its Precursor Lesions – A Nested Case Control Study and Review of Literature

  2023cites this paper
• Targeted RASSF1A expression inhibits proliferation of HER2‑positive breast cancer cells in vitro.

  2023cites this paper
• Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2− Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2− Breast Cancer

  2021cites this paper
• RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2

  2021influential citation
• RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)

  2020influential citation
• Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer

  2020cites this paper
• Differential colorectal cancer genomics between east and west

  2019cites this paper
• Tumor suppressor C-RASSF proteins

  2018cites this paper
• Suppressive efficiency of RASSF1A in endometrial carcinoma via inhabiting estrogen receptor alpha expression and ERK pathway activation.

  2018cites this paper
• Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells

  2017cites this paper
• KIBRA attains oncogenic activity by repressing RASSF1A

  2017cites this paper
• Investigating telomerase regulation in human breast cancer cells: a search for telomerase repressor sequences localised to chromosome 3P

  2015cites this paper
• CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers.

  2015cites this paper
• The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor‐positive breast cancer

  2015influential citation
• Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis.

  2015cites this paper
• DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.

  2014cites this paper
• Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

  2014cites this paper
• DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2.

  2014cites this paper
• Male breast cancer: genetics, epigenetics, and ethical aspects.

  2013cites this paper
• Different methylation and MicroRNA expression pattern in male and female familial breast cancer

  2013cites this paper
• RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.

  2013cites this paper
• Efeito do ácido docosahexaenoico (DHA) sobre eventos epigenéticos em diferentes linhagens de câncer de mama

  2013cites this paper
• Ras-Association Domain Family 1c protein enhances Breast Tumor Growth In Vivo

  2012cites this paper
• Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.

  2012cites this paper